PADDI Trial recruits first patient

Congratulations to the PADDI Trial team for recruiting their first patient today at The Alfred Hospital.

PADDI (Perioperative ADministration of Dexamethasone and Infection) Trial aims to definitely establish the safety profile of dexamethasone in the perioperative setting with the primary outcome being surgical site infection within 30 days. It will recruit 8800 patients internationally.

To read more about the trial visit:

To register your interest, email Jaspreet Sidhu, PADDI Trial Manager

Research Path is proud to provide the randomisation, CRF design, eCRF platform, and data management for this important clinical trial.

Return to News